AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|
32 C
New York
Tuesday, June 30, 2026

Tag: medical

Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline...

Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline...

Mountain Laurel Dermatology Notifies Individuals of Data Security Incident

ASHEVILLE, N.C., July 10, 2025 /PRNewswire/ -- Mountain Laurel Dermatology ("MLD") is providing notice of a recent data security incident that may have involved personal...

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy

SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the appointment of Marc. R Theoret, M.D. to assume the newly created position of Senior Vice President, Regulatory Strategy, where he will focus on clinical regulatory strategy for Iovance’s pipeline. Effective immediately, Dr. Theoret will report to Dr. Raj K. Puri, M.D., Ph.D., Chief Regulatory Officer.

Make-A-Wish and ESPN team up for the 18th season of the “My Wish” series

Since 2006, the summer series has showcased more than 80 inspiring stories of wish kids meeting their favorite teams and athletes PHOENIX, July 10, 2025...

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 5,242,464 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.763 per share of common stock (or per common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, SeaStar Medical will issue and sell unregistered warrants to purchase up to 5,242,464 shares of common stock. The warrants will have an exercise price of $0.638 per share, will be exercisable immediately upon issuance and will expire five years following the effective date of the resale registration statement registering the shares of common stock issuable upon exercise of the warrants.

Orlando Health Named Title Partner of Major League Pickleball’s Florida Smash

ST. PETERSBURG, Fla., July 10, 2025 /PRNewswire/ -- Major League Pickleball's Florida team, the Florida Smash, announced today Orlando Health as its title sponsor...

Viceroy Bali Receives 2025 Global Recognition Award for Bali’s Best Luxury Resort

BALI, Indonesia, July 10, 2025 (GLOBE NEWSWIRE) -- Global Recognition Awards™ has honored Viceroy Bali with a 2025 Global Recognition Award for Bali’s Best Luxury Resort, celebrating the property’s outstanding achievements in luxury hospitality and its ongoing commitment to excellence in the industry. The award recognizes the resort's exceptional standards in luxury hospitality, following its previous recognition as the World's #1 Resort by Condé Nast Traveler in 2018 and multiple World Luxury Hotel Awards, including Best Luxury Honeymoon Resort Worldwide in 2024.

LevEllis, Inc. Announces the Launch of PROVOQUE™: A Revolutionary Regenerative Skincare Serum

ASHEVILLE, N.C., July 10, 2025 /PRNewswire/ -- LevEllis, Inc. a pioneering skincare company founded by renowned surgeon and molecular biologist, Laura Ellis, MD, and...

Medline launches new ComfortTemp® Patient Warming System with blankets and gowns

System built to provide effective body-temperature control; features lock-in hose connection and flexible design NORTHFIELD, Ill., July 10, 2025 /PRNewswire/ -- Medline today officially announced the...

miraDry® Secures EU MDR Certification and Expands Indications for Sweat, Odor, and Hair Reduction Across Europe

NEWPORT BEACH, Calif., July 10, 2025 /PRNewswire/ -- miraDry®, Inc., a global leader in underarm sweat and odor treatment, announced today it has now...

Summer Solutions: PG&E Helps Customers Plug into Savings and Support

Energy Savings Start with the Right Tools, Simple Actions & Assistance Programs OAKLAND, Calif. , July 10, 2025 /PRNewswire/ -- With above-average temperatures forecast to hit...

Study Finds Link Between Brain Injury and Criminal Behavior

Study shows criminality is associated with damage to a key brain pathway involved in emotional control and judgment  AURORA, Colo., July 10, 2025 /PRNewswire/ --...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedical